Literature DB >> 28138957

Role of inducible nitric oxide synthase in endothelium-independent relaxation to raloxifene in rat aorta.

Chi Ming Wong1,2,3, Chak Leung Au3, Suk Ying Tsang4, Chi Wai Lau3, Xiaoqiang Yao3, Zongwei Cai1,2, Arthur Chi-Kong Chung1,2.   

Abstract

BACKGROUND AND
PURPOSE: Raloxifene can induce both endothelium-dependent and -independent relaxation in different arteries. However, the underlying mechanisms by which raloxifene triggers endothelium-independent relaxation are still incompletely understood. The purpose of present study was to examine the roles of NOSs and Ca2+ channels in the relaxant response to raloxifene in the rat isolated, endothelium-denuded aorta. EXPERIMENTAL APPROACH: Changes in isometric tension, cGMP, nitrite, inducible NOS protein expression and distribution in response to raloxifene in endothelium-denuded aortic rings were studied by organ baths, radioimmunoassay, Griess reaction, western blot and immunohistochemistry respectively. KEY
RESULTS: Raloxifene reduced the contraction to CaCl2 in a Ca2+ -free, high K+ -containing solution in intact aortic rings. Raloxifene also acutely relaxed the aorta primarily through an endothelium-independent mechanism involving NO, mostly from inducible NOS (iNOS) in vascular smooth muscle layers. This effect of raloxifene involved the generation of cGMP and nitrite. Also, it was genomic in nature, as it was inhibited by a classical oestrogen receptor antagonist and inhibitors of RNA and protein synthesis. Raloxifene-induced stimulation of iNOS gene expression was partly mediated through activation of the NF-κB pathway. Raloxifene was more potent than 17β-estradiol or tamoxifen at relaxing endothelium-denuded aortic rings by stimulation of iNOS. CONCLUSIONS AND IMPLICATIONS: Raloxifene-mediated vasorelaxation in rat aorta is independent of a functional endothelium and is mediated by oestrogen receptors and NF-κB. This effect is mainly mediated through an enhanced production of NO, cGMP and nitrite, via the induction of iNOS and inhibition of calcium influx through Ca2+ channels in rat aortic smooth muscle.
© 2017 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28138957      PMCID: PMC5368050          DOI: 10.1111/bph.13733

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  47 in total

1.  Animal research: reporting in vivo experiments: the ARRIVE guidelines.

Authors:  Carol Kilkenny; William Browne; Innes C Cuthill; Michael Emerson; Douglas G Altman
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

2.  Endothelium-independent relaxation to raloxifene in porcine coronary artery.

Authors:  Hok Sum Leung; Sai Wang Seto; Yiu Wa Kwan; Fung Ping Leung; Alice Lai Shan Au; Lai Ming Yung; Xiaoqiang Yao; Yu Huang
Journal:  Eur J Pharmacol       Date:  2006-10-20       Impact factor: 4.432

3.  The acute estrogenic dilation of rat aorta is mediated solely by selective estrogen receptor-alpha agonists and is abolished by estrogen deprivation.

Authors:  Chiara Bolego; Andrea Cignarella; Paola Sanvito; Valeria Pelosi; Fabio Pellegatta; Lina Puglisi; Christian Pinna
Journal:  J Pharmacol Exp Ther       Date:  2005-02-18       Impact factor: 4.030

4.  Raloxifene relaxes rat intrarenal arteries by inhibiting Ca2+ influx.

Authors:  Fung Ping Leung; Xiaoqiang Yao; Chi-Wai Lau; Wing-Hung Ko; Limin Lu; Yu Huang
Journal:  Am J Physiol Renal Physiol       Date:  2005-02-15

5.  Overexpression of inducible nitric oxide synthase by neointimal smooth muscle cells.

Authors:  Z Yan; G K Hansson
Journal:  Circ Res       Date:  1998 Jan 9-23       Impact factor: 17.367

6.  Estrogen causes dynamic alterations in endothelial estrogen receptor expression.

Authors:  Christopher E Ihionkhan; Ken L Chambliss; Linda L Gibson; Lisa D Hahner; Michael E Mendelsohn; Philip W Shaul
Journal:  Circ Res       Date:  2002-11-01       Impact factor: 17.367

7.  The Concise Guide to PHARMACOLOGY 2015/16: Enzymes.

Authors:  Stephen Ph Alexander; Doriano Fabbro; Eamonn Kelly; Neil Marrion; John A Peters; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Christopher Southan; Jamie A Davies
Journal:  Br J Pharmacol       Date:  2015-12       Impact factor: 8.739

8.  Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women.

Authors:  Elizabeth Barrett-Connor; Lori Mosca; Peter Collins; Mary Jane Geiger; Deborah Grady; Marcel Kornitzer; Michelle A McNabb; Nanette K Wenger
Journal:  N Engl J Med       Date:  2006-07-13       Impact factor: 91.245

9.  Significant fall in hormone replacement therapy prescription in general practice.

Authors:  Alm Lagro-Janssen; M W A Knufing; L Schreurs; C van Weel
Journal:  Fam Pract       Date:  2010-04-20       Impact factor: 2.267

10.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

Authors:  Jacques E Rossouw; Garnet L Anderson; Ross L Prentice; Andrea Z LaCroix; Charles Kooperberg; Marcia L Stefanick; Rebecca D Jackson; Shirley A A Beresford; Barbara V Howard; Karen C Johnson; Jane Morley Kotchen; Judith Ockene
Journal:  JAMA       Date:  2002-07-17       Impact factor: 56.272

View more
  4 in total

1.  Bazedoxifene-induced vasodilation and inhibition of vasoconstriction is significantly greater than estradiol.

Authors:  Margaret A Zimmerman; Dillion D Hutson; Franck Mauvais-Jarvis; Sarah H Lindsey
Journal:  Menopause       Date:  2019-02       Impact factor: 2.953

2.  Rapid vasodilation to raloxifene: role of oestrogen receptors and off-target effects.

Authors:  Matthias Barton; Eric R Prossnitz
Journal:  Br J Pharmacol       Date:  2017-10-06       Impact factor: 8.739

3.  Estrogen relaxes gastric muscle cells via a nitric oxide- and cyclic guanosine monophosphate-dependent mechanism: A sex-associated differential effect.

Authors:  Othman A Al-Shboul; Mona S Nazzal; Ayman G Mustafa; Ahmed N Al-Dwairi; Mohammad A Alqudah; Amal Abu Omar; Mahmoud A Alfaqih; Mohammad I Alsalem
Journal:  Exp Ther Med       Date:  2018-07-04       Impact factor: 2.447

4.  Terminalia fagifolia Mart. & Zucc. elicits vasorelaxation of rat thoracic aorta through nitric oxide and K+ channels dependent mechanism.

Authors:  Emanuella F de Carvalho; André F Nunes; Náiguel C B Silva; João Paulo da Silva Gomes; Renato P de Sousa; Valdelânia G Silva; Paulo H M Nunes; Rosimeire F Santos; Mariana H Chaves; Aldeidia P Oliveira; Rita C M Oliveira
Journal:  Biol Open       Date:  2019-02-27       Impact factor: 2.422

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.